Contact Us
lf you have any queries, get in touch today! Don't hesitate, We try to take the extra step forour customer satisfaction.
"
Our certificate
Possess 800 square meters of Class 10,000 dust-free workshop, Passed ISO9001:2015 quality management system certification and ISO13485:2016 medical device quality management system, and its products have obtained multiple biocompatibility tests, US FDA and EU LFGB certifications.
New
Our silicone accessories meet international medical standards through strict quality control.
Ensure patient safety with our premium products. Explore our catalog today!
News
Our silicone accessories meet international medical standards through strict quality control.
Ensure patient safety with our premium products. Explore our catalog today!
top Reco Without Post-Curing, Would You Use This Silicone Part in a Medical Device?
Post-curing is an essential step in medical silicone manufacturing that cannot be skipped. Without it, residual unreacted substances and low-molecular-weight cyclics can cause leachable contamination, cytotoxicity failure, performance drift, and odor. Buyers should verify post-curing by reviewing batch records, smell testing, requesting data, and on-site audits. Post-curing is a fundamental requirement for medical-grade quality.
top Reco EXNAN: The Precision Silicone Partner Trusted by Implantable Device Manufacturers
The global implantable silicone components market is expanding rapidly. Manufacturers require suppliers with proven quality systems, biocompatibility certification, and precise manufacturing capabilities. EXNAN has become a preferred partner for implantable silicone part producers, offering custom OEM solutions for critical applications such as implantable port sealing plugs and base assemblies. With over 20 years of engineering experience, a 10+ year production quality team, and in-house testin
Liquid Medical Silicone | Market Trends & Material Innovation 2026
Liquid silicone rubber (LSR) is increasingly used for precision medical components. The global LSR market is projected to grow from USD 3.71 billion (2025) to USD 8.80 billion by 2034 (CAGR 10.07%), driven by minimally invasive devices, drug delivery, and wearables. Material innovations include self-adhesive, self-lubricating, and emerging self-healing LSR — expanding possibilities for implantable and long-term drug delivery applications.
Recent News
—